Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke Patients
Background and Purpose In patients with acute ischemic stroke (AIS) using a direct oral factor-Xa anticoagulant (DOAC) during the last 48 hours, a fixed plasma heparin-calibrated anti-Xa activity (0.5 IU/mL) was proposed as a threshold below which patients could be eligible for thrombolysis and/or t...
Main Authors: | , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Korean Stroke Society
2023-01-01
|
Colecção: | Journal of Stroke |
Assuntos: | |
Acesso em linha: | http://www.j-stroke.org/upload/pdf/jos-2022-03034.pdf |